Founded
2012
Focus
Small Molecules
About
neurolixis
Funding History
2Total raised: $17.5M
Series A$15MPontifaxSep 15, 2021
Seed$2.5MUndisclosedJun 15, 2018
Company Info
TypePrivate
Founded2012
LocationParis, France
StagePhase 2
Contact
SIMILAR COMPANIES
4P-Pharma
Phase 2 · Lille
Patheon
Pre-clinical · Lyon
ABL Diagnostics
Pre-clinical · Strasbourg
Acticor Biotech
Pre-clinical · Paris
Adjuvatis
Pre-clinical · Lyon
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile